Skip to content

CBD: all studies

Page 7 of 38: studies 61 to 70 of 375, newest first. Back to the CBD overview

Research

Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model

Frontiers in Pharmacology April 18, 2023 María Salud García-Gutiérrez, Daniela Navarro, Amaya Austrich-Olivares et al.

Introduction: This study aims to further characterize cannabidiol’s pharmacological and molecular profile as an antidepressant.Methods: Effects of cannabidiol (CBD), alone or combined with sertraline (STR), were evaluated in male CD1 mice (n = 48) exposed to an unpredictable chronic mild stress (UCMS) procedure. Once the model was established (4 weeks), mice received CBD (20 mg·kg-1, i.p.), STR...

Potential Utility of Cannabidiol in Stress-Related Disorders.

Cannabis and Cannabinoid Research April 2023 Nicole A Lookfong, Wesley M Raup-Konsavage, Yuval Silberman

Background: The endocannabinoid (eCB) system plays an important role in homeostatic regulation of anxiety and stress responses; however, the eCB system can be disrupted following traumatic stressors. Additionally, traumatic or chronic stressors that occur during adulthood or early life can cause long-lasting disturbances in the eCB system. These alterations interfere with...

Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report.

Cureus April 2023 Mohamad K Moussa, Mary Ann Kirkconnell Hall, Joyce Akwe

In the United States, cannabis use is rising, including among older adults, as is unintentional ingestion. We describe the case of a 94-year-old woman admitted with altered mental status, diarrhea, and hallucinations. She lived with her family, who had noticed recent confusion with weakness, poor oral intake, and loose bowel movements. In the emergency room, her vital signs revealed mild...

DOI: 10.7759/cureus.37927 (opens in new tab) Full text (opens in new tab) Cannabidiol CBD Cannabis oil Elderly cannabis use Elderly individuals +3

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.

International Journal of Molecular Sciences March 9, 2023 Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca et al.

Cannabis is the most used drug of abuse worldwide. It is well established that the most abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These two compounds have remarkably similar chemical structures yet vastly different effects in the brain. By binding to the same receptors, THC is psychoactive, while CBD has anxiolytic and antipsychotic...

The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review.

European Journal of Clinical Pharmacology March 2023 Ehsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi et al.

Previous studies have shown that tetrahydrocannabinol (THC), the main psychoactive component of cannabis, can impair cognitive abilities. There is also some evidence that cannabidiol (CBD), the most abundant non-intoxicating constituent of cannabis, can attenuate these effects. The purpose of this study was to investigate the effects of THC:CBD oromucosal spray (with equal parts THC and CBD) on...

The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment

Addiction February 8, 2023 Will Lawn, Katie Trinci, Claire Mokrysz et al. 36 citations

Abstract Background and Aims Long‐term harms of cannabis may be exacerbated in adolescence, but little is known about the acute effects of cannabis in adolescents. We aimed to (i) compare the acute effects of cannabis in adolescent and adult cannabis users and (ii) determine if cannabidiol (CBD) acutely modulates the effects of delta‐9‐tetrahydocannabinol (THC). Design Randomised, double‐blind,...

Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.

JAMA Network Open February 1, 2023 C Austin Zamarripa, Tory R Spindle, Renuka Surujunarain et al.

Controlled clinical laboratory studies have shown that cannabidiol (CBD) can sometimes attenuate or exacerbate the effects of Δ9-tetrahydrocannabinol (Δ9-THC). No studies have evaluated differences in pharmacokinetics (PK) of Δ9-THC and pharmacodynamics (PD) between orally administered cannabis extracts that vary with respect to Δ9-THC and CBD concentrations. To compare the PK and PD of orally...

Perceptions about THC and CBD effects among adults with and without prior cannabis experience.

Addictive Behaviors February 2023 Toni C Spinella, Jeremy Bartholomeusz, Sherry H Stewart et al.

Cannabis is associated with a range of therapeutic and non-therapeutic, positive and negative effects. While some benefits and harms may be specific to individual cannabinoid constituents (THC, CBD), individual expectancies may also play a role. Evaluate the extent to which individuals hold expectancies about the effects of CBD, THC, and THC & CBD combined, and whether this differs with prior...

Effects of inhaled cannabis high in Δ9-THC or CBD on the aging brain: A translational MRI and behavioral study

Frontiers in Aging Neuroscience February 1, 2023 Aymen H. Sadaka, Justin Canuel, Marcelo Febo et al. 29 citations

With the recent legalization of inhaled cannabis for medicinal and recreational use, the elderly represents one of the newest, rapidly growing cohorts of cannabis users. To understand the neurobiological effects of cannabis on the aging brain, 19-20 months old mice were divided into three groups exposed to vaporized cannabis containing ~10% Δ9-THC, ~10% CBD, or placebo for 30 min each day....

THC and CBD: Similarities and differences between siblings.

Neuron February 1, 2023 Nephi Stella

Δ9-tetrahydrocannabinol (THC) and its sibling, cannabidiol (CBD), are produced by the same Cannabis plant and have similar chemical structures but differ dramatically in their mechanisms of action and effects on brain functions. Both THC and CBD exhibit promising therapeutic properties; however, impairments and increased incidence of mental health diseases are associated with acute and chronic...